DaVita said consolidated revenues for Q4 2024 were $3.295 billion and $12.816 billion for the full year, and operating income for Q4 was $565 million, with adjusted operating income of $491 million.

1. 01

   DaVita said consolidated revenues for Q4 2024 were $3.295 billion and $12.816 billion for the full year, and operating income for Q4 was $565 million, with adjusted operating income of $491 million.

2. 02

   The company said it reflected approximately $24.2 million in U.S. dialysis center closure costs in Q4 and repurchased 2.3 million shares for $367 million in the same quarter, at an average price paid of $156.46 per share.

3. 03

   DaVita disclosed operating cash flow of $548 million and free cash flow of $281 million for Q4 2024, and operating cash flow of $2,022 million and free cash flow of $1,162 million for the full year.

4. 04

   The company provided 2025 guidance for adjusted operating income of $2,010 million to $2,160 million and free cash flow of $1,000 million to $1,250 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.